Volume 22 Issue 12
Dec.  2024
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2024  >  22(12): 2037-2040
ZHAO Yunqi, XIE Changhao, ZHOU Ying. Analysis of clinical features and related factors of systemic lupus erythematosus complicated with cardiovascular disease[J]. Chinese Journal of General Practice, 2024, 22(12): 2037-2040. doi: 10.16766/j.cnki.issn.1674-4152.003792
Citation: ZHAO Yunqi, XIE Changhao, ZHOU Ying. Analysis of clinical features and related factors of systemic lupus erythematosus complicated with cardiovascular disease[J]. Chinese Journal of General Practice, 2024, 22(12): 2037-2040. doi: 10.16766/j.cnki.issn.1674-4152.003792
shu

Analysis of clinical features and related factors of systemic lupus erythematosus complicated with cardiovascular disease

doi: 10.16766/j.cnki.issn.1674-4152.003792

  • Department of Rheumatology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233004, China

Funds:

 2108085MH258

 2020byzd103

  • Received Date: 2024-05-06
    Available Online: 2025-01-20
    Abstract
  •   Objective  To examine the clinical characteristics and potential risk factors associated with systemic lupus erythematosus (SLE) patients with cardiovascular diseases. The findings of this study will contribute to the development of more accurate clinical diagnosis and treatment strategies for SLE patients with cardiovascular diseases.  Methods  The clinical data of 202 patients with SLE, comprising 22 males and 180 females, were collected from the Rheumatology Department of the First Affiliated Hospital of Bengbu Medical University between December 2021 and December 2022. The patients were divided into two groups: a case group comprising 58 patients with cardiovascular diseases and a control group comprising 144 patients without cardiovascular diseases. The clinical data of the two groups were subjected to analysis and comparison.  Results  There were a total of 58 SLE patients with cardiovascular diseases, with an incidence rate of 28.7%. There were statistically significant differences in age, left common carotid artery resistance index, left common carotid artery maximum blood flow velocity, blood glucose, platelet count, IgG level, C3, total cholesterol, D-dimer, antiphospholipid antibody positive rate, and disease duration between the two groups (P < 0.05). Logistic regression analysis showed that increased age, elevated left common carotid artery resistance index, hyperglycemia, platelet count, and abnormal IgG level were independent risk factors for SLE patients with cardiovascular diseases (P < 0.05).  Conclusion  The incidence rate of SLE patients with cardiovascular diseases is influenced by multiple factors, among which age increase, positive antiphospholipid antibody status, elevated left common carotid artery resistance index, abnormal blood glucose, platelet count, and abnormal IgG level are potential risk factors. It is therefore recommended that these factors should be taken into account in clinical practice in order to develop comprehensive risk assessment and management strategies which will effectively reduce the risk of cardiovascular disease in patients with SLE.

     

    • FullText(HTML)
  • loading
    • References(19)
  • [1]
    XU Y Q, GAO R, ZHANG M, et al. Deletion of the mitochondrial membrane protein Fam210b is associated with the development of systemic lupus erythematosus[J]. Int J Mol Sci, 2024, 25(13): 7253. DOI: 10.3390/ijms25137253.
    [2]
    KRISTENSEN S, DUCH K, SOUSSI B, et al. Temporal trends in mortality in patients with systemic lupus erythematosus: a Danish population-based matched cohort study[J]. Rheumatology(Oxford), 2024, 63(9): 2442-2449. doi: 10.1093/rheumatology/keae244
    [3]
    BUCCI T, CARDAMONE C, TRIGGIANI M, et al. Risk of death, thrombotic and hemorrhagic events in anticoagulated patients with atrial fibrillation and systemic autoimmune diseases: an analysis from a global federated dataset[J]. Clin Res Cardiol, 2024, 113(6): 942-950. doi: 10.1007/s00392-024-02426-1
    [4]
    CHEN P Y, TSAN Y, YANG C, et al. Prediction of risk of ischemic heart disease in first-diagnosed systemic lupus erythematosus patients in taiwan: is air pollution exposure a risk factor?[J]. BMC Rheumatology, 2023, 7(1): 14. DOI: 10.1186/s41927-023-00337-8.
    [5]
    谢长好, 李志军. 系统性红斑狼疮的诊断与治疗[J]. 中华全科医学, 2020, 18(4): 527-528. http://www.zhqkyx.net/article/id/240c4592-9f47-4c70-a324-2bf8221505c8

    XIE C H, LI Z J. Diagnosis and treatment of systemic lupus erythematosus[J]. Chinese Journal of General Practice, 2020, 18(4): 527-528. http://www.zhqkyx.net/article/id/240c4592-9f47-4c70-a324-2bf8221505c8
    [6]
    FORYCIARZ A, PFOHL S R, PATEL B, et al. Evaluating algorithmic fairness in the presence of clinical guidelines: the case of atherosclerotic cardiovascular disease risk estimation[J]. BMJ Health Care Inform, 2022, 29(1): e100460. DOI: 10.1136/bmjhci-2021-100460.
    [7]
    USUKU H, YAMAMOTO E, SAKATA K, et al. Usefulness of platelet count to predict concomitant valvular heart disease in patients with systemic lupus erythematosus[J]. Int J Cardiol Heart Vasc, 2024, 53: 101420. DOI: 10.1016/j.ijcha.2024.101420.
    [8]
    MAK A, CHAN J K Y. Endothelial function and endothelial progenitor cells in systemic lupus erythematosus[J]. Nat Rev Rheumatol, 2022, 18(5): 286-300. doi: 10.1038/s41584-022-00770-y
    [9]
    KHAYATA M, WANG T K M, CHAN N, et al. Multimodality cardiac imaging in patients with systemic lupus erythematosus[J]. Curr Probl Cardiol, 2023, 48(3): 101048. DOI: 10.1016/j.cpcardiol.2021.101048.
    [10]
    黄艳荣, 季兰岚, 高岱, 等. 系统性红斑狼疮亚临床动脉粥样硬化及相关因素的研究[J]. 中华风湿病学杂志, 2020, 24(12): 820-825. doi: 10.3760/cma.j.c141217-20200205-00034

    HUANG Y R, JI L L, GAO D, et al. Study on subclinical atherosclerosis and related factors in systemic lupus erythematosus[J]. Chinese Journal of Rheumatology, 2020, 24(12): 820-825. doi: 10.3760/cma.j.c141217-20200205-00034
    [11]
    高岱, 张卓莉. 达标治疗策略下系统性红斑狼疮中应用糖皮质激素的理念和发展[J]. 中华全科医学, 2023, 21(8): 1279-1283. doi: 10.16766/j.cnki.issn.1674-4152.003102

    GAO D, ZHANG Z L. Concept and development of glucocorticoid application in systemic lupus erythematosus under the targeted therapy strategy[J]. Chinese Journal of General Practice, 2023, 21(8): 1279-1283. doi: 10.16766/j.cnki.issn.1674-4152.003102
    [12]
    方茹梦, 狄宁宁, 郑倩倩, 等. 系统性红斑狼疮患者血清B细胞活化因子表达水平与颈动脉粥样硬化及其相关因素的关系[J]. 中华全科医学, 2022, 20(3): 371-374. doi: 10.16766/j.cnki.issn.1674-4152.002355

    FANG R M, DI N N, ZHENG Q Q, et al. The relationship between the expression level of serum B-cell activating factor in patients with systemic lupus erythematosus and carotid atherosclerosis and its related factors[J]. Chinese Journal of General Practice, 2022, 20(3): 371-374. doi: 10.16766/j.cnki.issn.1674-4152.002355
    [13]
    许晓风, 崔莉, 王艳红, 等. 264例系统性红斑狼疮患者抗磷脂抗体与抗核抗体, 抗双链DNA抗体关系的研究[J]. 标记免疫分析与临床, 2023, 30(1): 1-6.

    XU X F, CUI L, WANG Y H, et al. Study on the relationship between antiphospholipid antibodies, antinuclear antibodies, and anti-double-stranded DNA antibodies in 264 patients with systemic lupus erythematosus[J]. Labelled Immunological Analysis and Clinical Practice, 2023, 30(1): 1-6.
    [14]
    李朝霞, 黎晓萱, 徐春雪, 等. 系统性红斑狼疮患者心外膜脂肪厚度与心血管疾病风险的相关性[J]. 暨南大学学报(自然科学与医学版), 2024, 45(1): 31-37.

    LI Z X, LI X X, XU C X, et al. Correlation between epicardial fat thickness and cardiovascular disease risk in patients with systemic lupus erythematosus[J]. Journal of Jinan University(Natural Science and Medical Edition), 2024, 45(1): 31-37.
    [15]
    WHITTIER M, BAUTISTA S R, ARORA S, et al. Systemic lupus erythematosus and antiphospholipid antibody syndrome as risk factors for acute coronary syndrome in young patients: analysis of the national inpatient sample[J]. J Clin Rheumatol, 2022, 28(3): 143-146. doi: 10.1097/RHU.0000000000001824
    [16]
    SHAMS-ELDIN A N, YAFASOVA A, FAURSCHOU M, et al. Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study[J]. Clin Rheumatol, 2022, 41(11): 3525-3536. doi: 10.1007/s10067-022-06302-z
    [17]
    PAPAZOGLOU N, KRAVVARITI E, KONSTANTONIS G, et al. The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus[J]. Rheumatology (Oxford), 2024, 63(1): 50-57. doi: 10.1093/rheumatology/kead184
    [18]
    LETSVALO B P, SCHMID-ZALAUDEK K, BRIX B, et al. Cardiometabolic risk factors and early indicators of vascular dysfunction: a cross-sectional cohort study in South African adolescents[J]. BMJ Open, 2021, 11(3): e042955. DOI: 10.1136/bmjopen-2020-042955.
    [19]
    XU M, LU Z Y. Early diagnostic value of carotid artery ultrasound parameters combined with epicardial adipose layer thickness in coronary heart disease[J]. World J Clin Cases, 2024, 12(17): 3004-3011. doi: 10.12998/wjcc.v12.i17.3004
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (82) PDF downloads(4) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return